FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leslie Shaw

Research Profile

Chemicals & Drugs

Disorders

Procedures

Physiology

Graft Rejection

Concepts & Ideas

Co-author Network

Publications

TOP 3
Selam Negash; Leslie M Shaw; John Q Trojanowski; David A Wolk; Sharon Xie; Christopher M Clark; Christos Davatzikos; Steven E Arnold
Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology.
David J Irwin; Virginia M-Y Lee; David J Libon; Leo F McCluskey; Corey T McMillan; John Powers; Katya Rascovsky; Leslie M Shaw; Jon B Toledo; John Q Trojanowski; Vivianna M Van Deerlin; David A Wolk; John H Woo; Elisabeth McCarty Wood; Steven E Arnold; Jonathan Bekisz; Ashley Boller; Johannes Brettschneider; Keerthi Chandrasekaran; Philip A Cook; Lauren B Elman; Murray Grossman
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis.
Corey T McMillan; Leslie M Shaw; Jon B Toledo; John Q Trojanoswki; Vivianna M Van Deerlin; David A Wolk; Brian Avants; David J Irwin; Murray Grossman
Can MRI screen for CSF biomarkers in neurodegenerative disease?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leslie Shaw (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Selam Negash; Leslie M Shaw; John Q Trojanowski; David A Wolk; Sharon Xie; Christopher M Clark; Christos Davatzikos; Steven E Arnold
Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2013;9(3):e89-95.
2013: David J Irwin; Virginia M-Y Lee; David J Libon; Leo F McCluskey; Corey T McMillan; John Powers; Katya Rascovsky; Leslie M Shaw; Jon B Toledo; John Q Trojanowski; Vivianna M Van Deerlin; David A Wolk; John H Woo; Elisabeth McCarty Wood; Steven E Arnold; Jonathan Bekisz; Ashley Boller; Johannes Brettschneider; Keerthi Chandrasekaran; Philip A Cook; Lauren B Elman; Murray Grossman
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2013;84(2):163-9.
2013: Corey T McMillan; Leslie M Shaw; Jon B Toledo; John Q Trojanoswki; Vivianna M Van Deerlin; David A Wolk; Brian Avants; David J Irwin; Murray Grossman
Can MRI screen for CSF biomarkers in neurodegenerative disease?
Neurology 2013;80(2):132-8.
2013: Jon B Toledo; John Q Trojanowski; David A Wolk; Steven E Arnold; Priyanka Bhatt; Xiao Da; Christos Davatzikos; Leslie M Shaw
Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI.
PloS one 2013;8(2):e55531.
2012: Jon B Toledo; John Q Trojanowski; Michael W Weiner; Clifford R Jack; William Jagust; Virginia M-Y Lee; Leslie M Shaw; Estefanía Toledo
Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2012;8(6):483-9.
2012: William T Hu; Howard I Hurtig; Jason Karlawish; Max Kuhn; Virginia M-Y Lee; Leo McCluskey; John C Morris; Richard Perrin; Eve Pickering; Leslie M Shaw; Andrew Siderowf; Holly Soares; Frank Swenson; John Q Trojanowski; Vivianna M Van Deerlin; Chengjie Xiong; Steven E Arnold; Yu Chen; Alice Chen-Plotkin; Christopher M Clark; Rebecca Craig-Schapiro; Lauren B Elman; Anne M Fagan; Murray Grossman; David M Holtzman
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
Neurology 2012;79(9):897-905.
2012: Michal J Figurski; Magdalena Korecka; Virginia M-Y Lee; Leslie M Shaw; Jon Toledo; John Q Trojanowski; hugo vanderstichele; Teresa Waligórska
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2012;8(4):250-60.
2012: Jon B Toledo; Sharon X Xie; Steven E Arnold; Johannes Brettschneider; Murray Grossman; William T Hu; Virginia M-Y Lee; Leslie M Shaw; John Q Trojanowski
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases.
Acta neuropathologica 2012;124(1):23-35.
2012: Ju-Hee Kang; John Q Trojanowski; hugo vanderstichele; Leslie M Shaw
Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Methods (San Diego, Calif.) 2012;56(4):484-93.
2012: Li-San Wang; Young Baek; Shu-Kai Chang; Malgorzata Knapik-Czajka; Virginia M-Y Lee; Susan Leight; Yuk Yee Leung; Leslie M Shaw; John Q Trojanowski; Christopher M Clark
Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2012;31(2):439-45.
2012: Michał J Figurski; Lee R Goldberg; Kathleen D Lake; Artur Nawrocki; Tomasz Pawiński; Donna Chojnowski; David DeNofrio; David O Taylor; Leslie M Shaw
Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parameters.
Annals of transplantation : quarterly of the Polish Transplantation Society 2012;17(1):68-78.
2012: Sunil Patel; Leslie M Shaw; John Q Trojanowski; Sharon X Xie; Steven E Arnold; Christopher M Clark; M Sean Grady; Eric M Jackson; Anica Law; Edward B Lee; Roy H Hamilton
Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus.
Fluids and barriers of the CNS 2012;9(1):7.
2011: Christos Davatzikos; Leslie M Shaw; Kayhan N Batmanghelich; Priyanka Bhatt; John Q Trojanowski
Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.
Neurobiology of aging 2011;32(12):2322.e19-27.
2011: Junxia X Tang; Dimitry Baranov; Maryellen F Eckenhoff; Mary Hammond; Leslie M Shaw; Roderic G Eckenhoff
Human Alzheimer and inflammation biomarkers after anesthesia and surgery.
Anesthesiology 2011;115(4):727-32.
2011: Jon B Toledo; John Q Trojanowski; hugo vanderstichele; Michael W Weiner; Sharon X Xie; Paul S Aisen; Charles DeCarli; Michal Figurski; Clifford R Jack; William Jagust; Virginia M-Y Lee; Ronald C. Petersen; Leslie M Shaw; Arthur W Toga; Estefanía Toledo
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI.
Acta neuropathologica 2011;122(4):401-13.
2011: Anne M Fagan; Els Coart; Mark A Mintun; John C Morris; Leslie M Shaw; John Q Trojanowski; hugo vanderstichele; Chengjie Xiong; David M Holtzman
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.
Archives of neurology 2011;68(9):1137-44.
2011: Magdalena A Korecka; Ravi Patel; Leslie M Shaw
Evaluation of performance of new, isotopically labeled internal standard ([13c2d4]RAD001) for everolimus using a novel high-performance liquid chromatography tandem mass spectrometry method.
Therapeutic drug monitoring 2011;33(4):460-3.
2011: Leslie M Shaw; Eric Siemers; Adam J Simon; Holly Soares; John Q Trojanowski; hugo vanderstichele; Kaj Blennow; Els Coart; Robert A Dean; Michal Figurski; Malgorzata Knapik-Czajka; Virginia M-Y Lee; Piotr Lewczuk; William Potter
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.
Acta neuropathologica 2011;121(5):597-609.
2011: Alice S Chen-Plotkin; William T Hu; Andrew Siderowf; Daniel Weintraub; Rachel Goldmann Gross; Howard I Hurtig; Sharon X Xie; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Leo McCluskey; Lauren Elman; Vivianna M Van Deerlin; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.
Annals of neurology 2011;69(4):655-63.
2010: Roy Hamilton; Sunil Patel; Edward B Lee; Eric M Jackson; Joanna Lopinto; Steven E Arnold; Christopher M Clark; Anuj Basil; Leslie M Shaw; Sharon X Xie; M Sean Grady; John Q Trojanowski
Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology.
Annals of neurology 2010;68(4):535-40.
2010: William T Hu; Alice Chen-Plotkin; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Leo McCluskey; Lauren Elman; Jason Karlawish; Howard I Hurtig; Andrew Siderowf; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.
Acta neuropathologica 2010;120(3):385-99.
2010: Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski; Leslie M Shaw
Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010;878(24):2209-16.
2010: Laurence Chan; Erica Hartmann; Diane M Cibrik; Matthew Cooper; Leslie M Shaw
Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients.
Transplantation 2010;90(1):31-7.
2010: William T Hu; Alice Chen-Plotkin; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Eve Pickering; Max Kuhn; Yu Chen; Leo McCluskey; Lauren Elman; Jason Karlawish; Howard I Hurtig; Andrew Siderowf; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.
Acta neuropathologica 2010;119(6):669-78.
2010: John Q Trojanowski; Hugo Vandeerstichele; Magdalena Korecka; Christopher M Clark; Paul S Aisen; Ronald C. Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Z Potter; Michael Weiner; Clifford R Jack; William J Jagust; Arthur W Toga; Virginia M-Y Lee; Leslie M Shaw
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2010;6(3):230-8.
2010: Bruce Kaplan; Robert S Gaston; Herwig-Ulf Meier-Kriesche; Roy D Bloom; Leslie M Shaw
Mycophenolic acid exposure in high- and low-weight renal transplant patients after dosing with mycophenolate mofetil in the Opticept trial.
Therapeutic drug monitoring 2010;32(2):224-7.
2010: Keri J Donaldson; Leslie M Shaw
Quantitation of tacrolimus in whole blood using high performance liquid chromatography-tandem mass spectrometry (HPLC-MS-MS).
Methods in molecular biology (Clifton, N.J.) 2010;603():479-87.
2010: Magdalena Korecka; Leslie M Shaw
Quantitation of sirolimus using liquid chromatography-tandem mass spectrometry (LC-MS-MS).
Methods in molecular biology (Clifton, N.J.) 2010;603():469-77.
2009: Michal J Figurski; Magdalena Korecka; Leona Fields; Teresa Waligórska; Leslie M Shaw
High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
Therapeutic drug monitoring 2009;31(6):717-26.
2009: Larry J Kricka; Michael Milone; Stephen R Master; Leslie M Shaw; Donald S Young; Rodellia Fontanilla; Treasa Smith; JoAnn Gardiner; David Cardamone; Marilyn Fleming; David G Rhoads
Effect of a variable magnetic field on clinical laboratory testing.
Clinical chemistry 2009;55(6):1249-50.
2009: Magdalena Korecka; Leslie M Shaw
Review of the newest HPLC methods with mass spectrometry detection for determination of immunosuppressive drugs in clinical practice.
Annals of transplantation : quarterly of the Polish Transplantation Society 2009;14(2):61-72.
2009: Leslie M Shaw; hugo vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C. Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
Annals of neurology 2009;65(4):403-13.
2008: Michal J Figurski; Artur Nawrocki; Mark D Pescovitz; Rene Bouw; Leslie M Shaw
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
Therapeutic drug monitoring 2008;30(4):445-55.
2008: M Murashima; H R Drott; D Carlow; Leslie M Shaw; Michael C Milone; M Bachman; Donald E Tsai; S-L Yang; R D Bloom
Removal of gadolinium by peritoneal dialysis.
Clinical nephrology 2008;69(5):368-72.
2008: Leslie M Shaw
PENN biomarker core of the Alzheimer's disease Neuroimaging Initiative.
Neuro-Signals 2008;16(1):19-23.
2007: Leslie M Shaw; Michal Figurski; Michael C Milone; Jennifer Trofe; Roy D Bloom
Therapeutic drug monitoring of mycophenolic acid.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(5):1062-72.
2007: Leslie M Shaw; Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.
Nature reviews. Drug discovery 2007;6(4):295-303.
2007: Manuel Haschke; Yan Ling Zhang; Christine Kahle; Jost Klawitter; Magdalena Korecka; Leslie M Shaw; Uwe Christians
HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma.
Clinical chemistry 2007;53(3):489-97.
2007: Jianhe Huang; Daisheng Song; Adrian Flores; Quan Zhao; Sharon M Mooney; Leslie M Shaw; Frank S Lee
IOP1, a novel hydrogenase-like protein that modulates hypoxia-inducible factor-1alpha activity.
The Biochemical journal 2007;401(1):341-52.
2006: Magdalena Korecka; Sandra G Solari; Leslie M Shaw
Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement.
Therapeutic drug monitoring 2006;28(4):484-90.
2005: Sandra G Solari; Lee R Goldberg; David DeNofrio; Leslie M Shaw
Cyclosporine monitoring with 2-hour postdose levels in heart transplant recipients.
Therapeutic drug monitoring 2005;27(4):417-21.
2004: Jonathan S Sussman; Susan C Brozena; Neal Skop; Magdalena Korecka; Leslie M Shaw
Accidental intravenous colchicine poisoning.
Therapeutic drug monitoring 2004;26(6):688-92.
2004: Leslie M Shaw; Arthur Nawrocki; Magdalena Korecka; Sandra G Solari; Juseop Kang
Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic acid plasma concentrations.
Therapeutic drug monitoring 2004;26(4):347-51.
2003: Constance M Yuan; Phillip R Spandorfer; Samuel L Miller; Fred M Henretig; Leslie M Shaw
Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose.
Therapeutic drug monitoring 2003;25(3):299-304.
2003: Leslie M Shaw; Magdalena Korecka; Raman Venkataramanan; Lee Goldberg; Roy D Bloom; Kenneth L Brayman
Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(5):534-42.
2003: Tomasz Pawiński; Leslie M Shaw
Stability of mycophenolic acid in plasma samples from patients during mycophenolate mofetil therapy.
Acta poloniae pharmaceutica 2003;60(2):121-4.
2002: Micha Levi; James A Knol; William D Ensminger; Susan J DeRemer; Chunzhi Dou; Susan M Lunte; Heather S Bonner; Leslie M Shaw; David E Smith
Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(12):1425-30.
2002: Ashok Kumar B Jain; Raman Venkataramanan; Jonathan A Fridell; Mary Gadomski; Leslie M Shaw; Margaret Ragni; Magdalena Korecka; John Fung
Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2002;8(9):838-40.
2002: Tomasz Pawinski; Mike Hale; Magdalena Korecka; William E Fitzsimmons; Leslie M Shaw
Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.
Clinical chemistry 2002;48(9):1497-504.
2002: Edgar Ben-Josef; Sue Han; Martin Tobi; Leslie M Shaw; Heather S Bonner; Barbara J Vargas; Sharon Prokop; Beth Stamos; Laura Kelly; Sandra Biggar; Irving Kaplan
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury.
International journal of radiation oncology, biology, physics 2002;53(5):1160-4.
2002: Heather S Bonner; Leslie M Shaw
New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion.
Journal of clinical pharmacology 2002;42(2):166-74.
2002: Leslie M Shaw; Tomasz Pawinski; Magdalena Korecka; Arthur Nawrocki
Monitoring of mycophenolic acid in clinical transplantation.
Therapeutic drug monitoring 2002;24(1):68-73.
2001: Leslie M Shaw; David Holt; M Oellerich; B Meiser; T van Gelder
Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion.
Therapeutic drug monitoring 2001;23(4):305-15.
2001: Raman Venkataramanan; Leslie M Shaw; L Sarkozi; R Mullins; J Pirsch; Gordon MacFarlane; DG Scheller; Diana L Ersfeld; M Frick; William E Fitzsimmons; Mohamed A Virji; Ashok Jain; Kenneth L Brayman; A Shaked
Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.
Journal of clinical pharmacology 2001;41(5):542-51.
2001: Leslie M Shaw; Magdalena Korecka; David DeNofrio; Kenneth L Brayman
Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.
Clinical biochemistry 2001;34(1):17-22.
2000: David DeNofrio; Evan Loh; Andrew Kao; Magdalena Korecka; Faith Pickering; K A Craig; Leslie M Shaw
Mycophenolic acid concentrations are associated with cardiac allograft rejection.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(11):1071-6.
2000: Leslie M Shaw; Magdalena Korecka; S Aradhye; Robert Grossman; L Bayer; C Innes; A Cucciara; C Barker; Ali Naji; A Nicholls; Kenneth L Brayman
Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable.
Journal of clinical pharmacology 2000;40(6):624-33.
2000: Miroslaw Majewski; Magdalena Korecka; Plamen Kossev; Shiqing Li; J Goldman; J Moore; Leslie E Silberstein; Peter C Nowell; Walter Schuler; Leslie M Shaw; Mariusz A Wasik
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(8):4285-90.
2000: Heather S Bonner; Leslie M Shaw
Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 2000;739(2):357-62.
2000: Herwig-Ulf Meier-Kriesche; Leslie M Shaw; M Korecka; Bruce Kaplan
Pharmacokinetics of mycophenolic acid in renal insufficiency.
Therapeutic drug monitoring 2000;22(1):27-30.
2000: Leslie M Shaw; B Kaplan; David DeNofrio; Magdalena Korecka; Kenneth L Brayman
Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation.
Therapeutic drug monitoring 2000;22(1):14-9.
2000: Leslie M Shaw; B Kaplan; K L Brayman
Advances in therapeutic drug monitoring for immunosuppressants: a review of sirolimus. Introduction and overview.
Clinical therapeutics 2000;22 Suppl B():B1-13.
1999: Gordon MacFarlane; Leslie M Shaw; Raman Venkataramanan; R Mullins; DG Scheller; Diana L Ersfeld
Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function.
Therapeutic drug monitoring 1999;21(6):585-92.
1999: Leslie M Shaw; David Holt; Paul Keown; Raman Venkataramanan; R W Yatscoff
Current opinions on therapeutic drug monitoring of immunosuppressive drugs.
Clinical therapeutics 1999;21(10):1632-52; discussion 1631.
1999: Gordon MacFarlane; DG Scheller; Diana L Ersfeld; Leslie M Shaw; R Venkatarmanan; L Sarkozi; R Mullins; B R Fox
Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood.
Clinical chemistry 1999;45(9):1449-58.
1999: Bruce Kaplan; Herwig-Ulf Meier-Kriesche; G Friedman; Shamkant Mulgaonkar; Scott A Gruber; Magdalena Korecka; Kenneth L Brayman; Leslie M Shaw
The effect of renal insufficiency on mycophenolic acid protein binding.
Journal of clinical pharmacology 1999;39(7):715-20.
1999: Magdalena Korecka; Dejan Nikolic; Richard B Van Breemen; Leslie M Shaw
The apparent inhibition of inosine monophosphate dehydrogenase by mycophenolic acid glucuronide is attributable to the presence of trace quantities of mycophenolic acid.
Clinical chemistry 1999;45(7):1047-50.
1999: Leslie M Shaw; Heather S Bonner; Lynn Schuchter; J Schiller; R Lieberman
Pharmacokinetics of amifostine: effects of dose and method of administration.
Seminars in oncology 1999;26(2 Suppl 7):34-6.
1999: Qian Zhang; B Lee; Magdalena Korecka; G Li; C Weyland; Stephen L Eck; A Gessain; N Arima; Stuart R Lessin; Leslie M Shaw; Selina M Luger; M Kamoun; Mariusz A Wasik
Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Leukemia research 1999;23(4):373-84.
1998: K Huang; David J Vaughn; Leslie M Shaw; Adri Recio; Heather S Bonner; Daniel G Haller
A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer.
American journal of clinical oncology 1998;21(6):548-52.
1998: Leslie M Shaw; Magdalena Korecka; S Aradhye; Robert Grossman; C Barker; Ali Naji; Kenneth L Brayman
Scientific principles for mycophenolic acid therapeutic drug monitoring.
Transplantation proceedings 1998;30(5):2234-6.
1998: Leslie M Shaw; Magdalena Korecka; R van Breeman; I Nowak; Kenneth L Brayman
Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.
Clinical biochemistry 1998;31(5):323-8.
1998: Leslie M Shaw; A Nicholls; M Hale; V W Armstrong; M Oellerich; R Yatscoff; R E Morris; David Holt; Raman Venkataramanan; J Haley; P Halloran; R Ettenger; Paul Keown; R G Morris
Therapeutic monitoring of mycophenolic acid. A consensus panel report.
Clinical biochemistry 1998;31(5):317-22.
1998: Leslie M Shaw; R Mick; I Nowak; Magdalena Korecka; Kenneth L Brayman
Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function.
Journal of clinical pharmacology 1998;38(3):268-75.
1998: Mariusz A Wasik; I Nowak; Qian Zhang; Leslie M Shaw
Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.
Leukemia & lymphoma 1998;28(5-6):551-60.
1998: Leslie M Shaw; B Kaplan; Kenneth L Brayman
Prospective investigations of concentration-clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring.
Clinical chemistry 1998;44(2):381-7.
1998: AF Eder; Cindy M McGrath; YG Dowdy; J E Tomaszewski; F M Rosenberg; R B Wilson; Bryan A Wolf; Leslie M Shaw
Ethylene glycol poisoning: toxicokinetic and analytical factors affecting laboratory diagnosis.
Clinical chemistry 1998;44(1):168-77.
1997: I Nowak; Leslie M Shaw
Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity.
Therapeutic drug monitoring 1997;19(3):358-60.
1997: I Nowak; J Wu; Kenneth L Brayman; Leslie M Shaw
Is the glucuronide metabolite of MPA pharmacologically active?
Transplantation proceedings 1997;29(1-2):337.
1997: Leslie M Shaw
Mycophenolate mofetil: pharmacokinetic strategies for optimizing immunosuppression.
Drug metabolism and drug interactions 1997;14(1):33-40.